IgG anti-spike antibody levels in healthcare workers with and without prior COVID-19 up to 3 months after BNT162b2 vaccination
Jan Van Elslande, Matthias Weemaes, Lode Godderis, Gijs Van Pottelbergh, Xavier Bossuyt, Pieter Vermeersch
Topics & Concepts
VaccinationCoronavirus disease 2019 (COVID-19)Spike ProteinMedicineAntibodySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Antibody response2019-20 coronavirus outbreakHealth careSpike (software development)VirologyImmunologyInternal medicineOutbreakComputer scienceDiseaseInfectious disease (medical specialty)EconomicsSoftware engineeringEconomic growthSARS-CoV-2 and COVID-19 ResearchMonoclonal and Polyclonal Antibodies ResearchHeparin-Induced Thrombocytopenia and Thrombosis